Acadia Healthcare Q1 2025 Earnings Report
Key Takeaways
In Q1 2025, Acadia Healthcare reported $770.5 million in revenue and $8.4 million in net income. Adjusted EPS reached $0.40 and Adjusted EBITDA came in at $134.2 million, including $5 million in one-time costs related to a facility closure. The company added 378 new beds and repurchased $47.3 million in stock.
Revenue rose slightly to $770.5 million, up 0.3% YoY.
Adjusted EPS was $0.40 vs. GAAP EPS of $0.09 due to non-recurring legal and restructuring costs.
378 new beds were added, making Q1 part of the largest expansion year in company history.
Acadia reaffirmed FY2025 guidance, including $3.3–$3.4 billion in revenue and $675–$725 million in Adjusted EBITDA.
Acadia Healthcare
Acadia Healthcare
Acadia Healthcare Revenue by Geographic Location
Forward Guidance
Acadia reaffirmed its full-year 2025 guidance, projecting stable growth with increased capital investment and expansion activity.
Positive Outlook
- Revenue expected between $3.3B and $3.4B.
- Adjusted EPS guidance maintained at $2.50–$2.80.
- Adjusted EBITDA forecast of $675M–$725M for FY25.
- Plan to add 800–1,000 beds by year-end remains on track.
- Strong liquidity with $91.2M cash and $901.6M available under credit facility.
Challenges Ahead
- Adjusted EBITDA impacted by $5M due to a facility closure.
- Free cash flow deeply negative due to expansion capex.
- Q1 GAAP EPS significantly lower due to legal and transaction costs.
- Revenue per patient day declined slightly YoY.
- Increased startup losses expected from new facilities, totaling $50–$55M for FY25.